Industry News

Industry News

Risk Of Melanoma Increased By Inflammatory Bowel Disease

May 22, 2013

Patients with inflammatory bowel disease(IBD) are at higher risk of melanoma, a form of skin cancer, report researchers at Mayo Clinic. Researchers found that IBD is associated with a 37 percent greater risk for the disease. The findings were presented at the Digestive Disease Week 2013 conference in Orlando, Fla. More than 1... Read More

Epigenetic Regulators And NF-Kappa B May One Day Be Targeted For The Treatment Of Cancer

May 22, 2013

In a new study described in the journal Oncogene, researchers reveal how a key player in cell growth, immunity and the inflammatory response can be transformed into a primary contributor to tumor growth. Scientists call this Jekyll-and-Hyde molecule NF-kappa B. In healthy cells, it is a powerful "first responder," a vital part of the body's immune and inflammatory responses... Read More

Few Simple Steps To Prevent Skin Cancer This Summer

May 21, 2013

Skin cancer remains the most common cancer in the U.S., and as summer is quickly approaching, Americans are encouraged to take a few simple steps to protect their health and prevent skin cancer throughout this upcoming season. The U.S... Read More

Phase III Trial Of L-BLP25 In Patients With Non-Small Cell Lung Cancer (START) - Primary Endpoint Of Significantly Improving Overall Survival Not Met

May 21, 2013

Confirmed: Primary endpoint of significantly improving overall survival not met Merck Serono, a division of Merck, Darmstadt, Germany, today announced detailed results from the randomized Phase III START* trial of its investigational MUC1 antigen-specific cancer immunotherapy L-BLP25 (formerly referred to as Stimuvax) in patients with unresectable, locally advanced Stage III... Read More

Outcome In Head And Neck Cancer Predicted By Genetic Diversity Within Tumors

May 21, 2013

A new measure of the heterogeneity - the variety of genetic mutations - of cells within a tumor appears to predict treatment outcomes of patients with the most common type of head and neck cancer... Read More

Software May Allow Doctors To Track Progression Of Cancer, Response To Treatment, And Risk Of Relapse

May 21, 2013

In their quest to learn more about the variability of cells between and within tissues, biomedical scientists have devised tools capable of simultaneously measuring dozens of characteristics of individual cells. These technologies have led to new challenges, however, as scientists now struggle with how to make sense of the resulting trove of data. Now a solution may be at hand... Read More

Ground-Breaking View Of Colon Provided By New Colonoscope

May 21, 2013

A ground-breaking advance in colonoscopy technology signals the future of colorectal care, according to research presented at Digestive Disease Week® (DDW). Additional research focuses on optimizing the minimal withdrawal time for colonoscopies and exploring safer methods for removing polyps. During colonoscopy, doctors use a device called a colonoscope to examine the colon... Read More

New Methods For Managing Digestive Health

May 21, 2013

Research presented at Digestive Disease Week® (DDW) explores new methods for managing digestive health through diet and lifestyle. Individuals suffering from Crohn's disease are often plagued by reduced muscle strength, fatigue and poor quality of life. These symptoms can remain even when patients are in remission... Read More

UK Aims To Make Genetic Testing Available To All Cancer Patients

May 21, 2013

A research program that should eventually allow all cancer patients to have access to genetic testing has been launched with £2.7 million ($4 million) funding from the Wellcome Trust... Read More

Cancer Survivors Suffer Physical & Emotional Impairments Which Often Go Untreated

May 21, 2013

A new review finds cancer survivors suffer a diverse and complex set of impairments, affecting virtually every organ system. Writing in CA: A Cancer Journal for Clinicians, Julie Silver, M.D... Read More

Previous Page   Next Page